Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kaname Sakamoto"'
Publikováno v:
Clinical Case Reports, Vol 10, Iss 10, Pp n/a-n/a (2022)
Abstract Hypersensitivity reaction to cisplatin can result in discontinuation of chemoradiotherapy in patients with head and neck squamous cell carcinoma. We describe a patient with nasopharyngeal carcinoma who developed cisplatin hypersensitivity an
Externí odkaz:
https://doaj.org/article/789153a5369649248bf34e3ede5516c6
Autor:
Hiroki Ishii, Takahiro Tsujikawa, Naoki Oishi, Arisa Kinouchi, Kaname Sakamoto, Junichi Mitsuda, Hiroshi Ogi, Kyoko Itoh, Tetsuo Kondo, Shigeru Hirano, Daiju Sakurai
Publikováno v:
Clinical Case Reports, Vol 10, Iss 7, Pp n/a-n/a (2022)
Abstract Metastatic intrathyroid thymic carcinoma (ITTC) is a rare cancer with no effective drugs for controlling. This case report has shown genomic and immune microenvironment profiles in metastatic ITTC and emphasized an immunosuppression via a PD
Externí odkaz:
https://doaj.org/article/d373a705f9384055b200dd210b07c07e
Autor:
Kaname Sakamoto, Kaori Endo, Kei Sakamoto, Kou Kayamori, Shogo Ehata, Jiro Ichikawa, Takashi Ando, Ryosuke Nakamura, Yujiro Kimura, Kunio Yoshizawa, Keisuke Masuyama, Tomoyuki Kawataki, Kunio Miyake, Hiroki Ishii, Tomonori Kawasaki, Keiji Miyazawa, Masao Saitoh
Publikováno v:
Oncogenesis, Vol 10, Iss 3, Pp 1-15 (2021)
Abstract ETS homologous factor (EHF) belongs to the epithelium-specific subfamily of the E26 transformation-specific (ETS) transcription factor family. Currently, little is known about EHF’s function in cancer. We previously reported that ETS1 indu
Externí odkaz:
https://doaj.org/article/afa69439fee24eea9cd6fcd85029e401
Autor:
Hiroki Ishii, Kazuaki Chikamatsu, Satoshi Igarashi, Hideyuki Takahashi, Kaname Sakamoto, Hiroji Higuchi, Shota Tanaka, Tomokazu Matsuoka, Keisuke Masuyama
Publikováno v:
Translational Oncology, Vol 11, Iss 1, Pp 132-139 (2018)
The lack of available tumor antigens with strong immunogenicity, human leukocyte antigen restriction, and immunosuppression via regulatory T-cells (Tregs) and myeloid-derived suppressor cells are limitations for dendritic cell (DC)–based immunother
Externí odkaz:
https://doaj.org/article/eabac27119d74a56b81ac258f66ffea3
Autor:
Asami Hotta Osada, Kaori Endo, Yujiro Kimura, Kei Sakamoto, Ryosuke Nakamura, Kaname Sakamoto, Koichiro Ueki, Kunio Yoshizawa, Keiji Miyazawa, Masao Saitoh
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0217451 (2019)
The epithelial-mesenchymal transition (EMT) is a crucial morphological event that occurs during epithelial tumor progression. ZEB1/2 are EMT transcription factors that are positively correlated with EMT phenotypes and breast cancer aggressiveness. ZE
Externí odkaz:
https://doaj.org/article/33bcd9aafef841648fc4883145a1192b
Autor:
Takahiro Yamanishi, Kaname Sakamoto, Hiroyuki Watanabe, Takaaki Yonaga, Naoki Oishi, Ryohei Katoh, Keisuke Masuyama
Publikováno v:
Case Reports in Otolaryngology, Vol 2014 (2014)
We encountered a patient with primary cervical leiomyoma with remarkable calcification and ossification. A 68-year-old man presenting with induration and swelling of the left submandibular region was found to have nodular lesions with calcifications
Externí odkaz:
https://doaj.org/article/297eb222182e479da4c9a75c03e277a2
Autor:
Kentaro Yoshimura, Hiroki Ishii, Daisuke Saigusa, Masao Saitoh, Kei Sakamoto, Keiji Miyazawa, Kei Ashizawa, Kaname Sakamoto, Hirotake Kasai, Keisuke Masuyama, Sen Takeda
Publikováno v:
British Journal of Cancer
Background Several pro-oncogenic signals, including transforming growth factor beta (TGF-β) signalling from tumour microenvironment, generate intratumoural phenotypic heterogeneity and result in tumour progression and treatment failure. However, the
Autor:
Yukihiro Hiraga, Kaname Sakamoto
Publikováno v:
Practica Oto-Rhino-Laryngologica. 113:437-444
Autor:
Kaname Sakamoto, Yukihiro Hiraga
Publikováno v:
Practica Oto-Rhino-Laryngologica. 113:733-739
Autor:
Jiro Ichikawa, Kunio Miyake, Masao Saitoh, Kaname Sakamoto, Kei Sakamoto, Shogo Ehata, Keisuke Masuyama, Ryosuke Nakamura, Takashi Ando, Tomoyuki Kawataki, Kaori Endo, Tomonori Kawasaki, Kou Kayamori, Yujiro Kimura, Hiroki Ishii, Kunio Yoshizawa, Keiji Miyazawa
Publikováno v:
Oncogenesis
Oncogenesis, Vol 10, Iss 3, Pp 1-15 (2021)
Oncogenesis, Vol 10, Iss 3, Pp 1-15 (2021)
ETS homologous factor (EHF) belongs to the epithelium-specific subfamily of the E26 transformation-specific (ETS) transcription factor family. Currently, little is known about EHF’s function in cancer. We previously reported that ETS1 induces expre